XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
OPERATING ACTIVITIES    
Net loss $ (1,026,530) $ (979,048)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of debt discount 564,596 52,623
Stock Compensation 5,000 350,643
Loss on settlement with officer and director 18,086
Loss on settlement of debt 195,216
Change in Operating Assets and Liabilities:    
Decrease (increase) in accounts receivable (10,000)
Decrease (increase) in deposits and prepaids 1,023 (32,436)
Increase (decrease) in accounts payable and accrued expenses 40,184 (5,335)
Increase (decrease) in accrued interest 84,948 28,288
Net Cash Used in Operating Activities (340,780) (371,963)
INVESTING ACTIVITIES    
Internal software development (800,363) (283,240)
Website (5,000)
Net cash provided by (used) in investing activities (805,363) (283,240)
FINANCING ACTIVITIES    
Proceeds from sale of common stock issuance 149,250 422,075
Proceeds from sale of common stock to be issued 50,000
Repayment of note principal (2,100)
Proceeds from note payable 125,000
Proceeds from convertible debt 1,300,000 60,000
Repurchase of common stock (50,000)
Net Cash Provided by Financing Activities 1,449,250 604,975
Net Increase (Decrease) in Cash and Equivalents 303,107 (50,228)
Cash and Equivalents at Beginning of the Period 4,067 54,295
Cash and Equivalents at End of the Period 307,174 4,067
SUPPLEMENTAL CASH FLOW INFORMATION    
Interest Paid 1,233 2,500
Income Taxes Paid
NON-CASH DISCLOSURES    
Beneficial conversion feature 1,292,500 110,000
Common stock issued for prepaid expense 4,849 119,260
Common stock issued for note payable 141,970
Common stock issued from to be issued $ 53,000